Fuse Medical, Inc.

Fuse Medical, Inc.

OOTC:FZMD
0.03
USD
-0.01
(-24.24%)
0.05EPS
1.20P/E
4.51MMarket Cap
2011 Y
2012 Y
2013 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
0.36
- -
0.25
0.27
3.57
1.65
0.39
0.33
0.3
0.29
0.25
0.26
Basic EPS, GAAP
-0.5
-0.42
0.15
- -
-0.37
-0.13
0.42
0.04
0.06
-0.05
-0.02
-0.02
0.04
0.05
Free Cash Flow per Basic Share
-0.55
-0.22
0.11
- -
-0.32
-0.06
0.39
0.1
0.04
- -
- -
-0.03
- -
- -
Dividend per Share
7.33
- -
0.07
- -
0.01
- -
0.33
0.12
- -
- -
- -
- -
- -
- -
Book Value per Share
0.24
-0.18
0.68
0.41
0.04
- -
0.67
-0.12
0.02
-0.02
-0.03
-0.05
- -
- -
Tangible Book Value per Share
0.24
-0.18
0.68
0.41
0.04
- -
0.62
-0.13
-0.04
-0.06
-0.07
-0.09
-0.05
-0.05
Basic Weighted Avg Shares
- -
- -
3
- -
4
6
7
16
68
70
70
70
74
71
Sales/Revenue/Turnover
- -
- -
1
- -
1
2
26
26
26
23
21
20
19
18
Operating Margin (%)
- -
- -
41.16
- -
-107.77
-47.24
12.32
3.23
-7.43
-14.92
-4.8
-10.75
-4.37
-1.3
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-1
3
1
4
-3
-1
-2
3
4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
5.51
- -
- -
- -
- -
0.76
0.72
Profit Margin (%)
- -
- -
41.1
- -
-149.3
-47.81
11.75
2.65
15.02
-14.48
-6.69
-7.78
16.62
19.72
Working Capital
- -
- -
- -
- -
- -
- -
10
10
10
6
5
3
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
11
-8
1
-1
-2
-3
- -
- -
Return on Invested Capital (%)
- -
- -
253.69
- -
- -
- -
50.77
- -
- -
- -
- -
- -
-270.32
-408.46
Return on Capital (%)
- -
- -
253.69
- -
- -
- -
44.68
17.69
- -
- -
- -
- -
471.17
1,077.28
Return on Common Equity (%)
-12.34
- -
- -
- -
-934.7
-787.91
56.89
- -
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
74
74
74
Market Capitalization
11
2
5

Working Capital

USD

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
14
12
13
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
4
3
3
Inventories
9
9
9
Total Current Liabilities
12
11
12
Payables & Accruals
10
9
10
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21,323.04%
-51.47%
-90.94%
Free Cash Flow
- -
-449.8%
-101.96%
Net Income, GAAP
- -
-11.85%
-295.11%
Sales/Revenue/Turnover
- -
-6.63%
-8.67%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
4
6
4
6
20
2022
5
5
5
5
19
2023
4
5
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.01
- -
-0.01
- -
-0.02
2022
-0.01
- -
- -
0.05
0.04
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

CEO
Christopher C. Reeg
Full Time Employees
31
Sector
Miscellaneous
Industry
Miscellaneous
Address
4343 Sigma Road Farmers Branch TX United States 75244
IPO Date
Oct 30, 1980
Business
Fuse Medical, Inc. (FZMD) manufactures, distributes and wholesales medical device implants focused on orthopedics and spine, offering orthopedic implants including internal and external fixation products for foot and ankle; upper and lower extremity plating systems; total joint reconstruction implants for knee, hip and shoulder; soft tissue fixation and suture anchors for sports medicine; spinal implants for cervical, thoracolumbar, trauma and interbody fusion; hammertoe implants; compression staples and headed/headless cannulated screws; as well as osteo-biologics and regenerative products such as human allografts, demineralized bone matrix, tendons, amniotic membrane, dermal matrix, wound care solutions, bone void fillers, platelet rich plasma and bone marrow aspirate concentrate. The company, founded in 1968 and headquartered in Farmers Branch, Texas, serves hospitals, ambulatory surgical centers, medical facilities and sub-distributors primarily in the United States. Fuse completed acquisitions of CPM Medical Consultants in 2019, enhancing its distribution network for joint reconstruction, sports medicine, trauma and biologics, and Maxim Surgical in 2018, expanding its spinal fusion device manufacturing capabilities; it continues to develop new products including the Fuse FPS Foot Plating System and sterile packaged systems for ambulatory settings.

Company News

  • Golf Rounds.com (OTCMKTS:FZMD) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why

  • Golf Rounds.com (OTCMKTS:FZMD) & Becton, Dickinson and Company (NYSE:BDX) Financial Survey

  • Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

  • Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix

  • Fuse Medical, Inc. Announces Initial Launch of Orbitum™ Compression Staple System

  • Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

  • Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

  • Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results

  • Fuse Medical, Inc. Announces Exclusive Agreement With Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum™ Staple System

  • Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth

  • Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio

  • Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19